CYTORA awarded
10th Grant by the
Israel Innovation
Authority...

Prof. Tanya Gurevich, M.D, presents interim phase I hOMSC 300 results for moderate to advanced MSA ...

Cytora Reports Phase
1 Data of Stem Cell
Treatment for Multiple
System Atrophy...

Cytora Reports
Successful Results of
Phase 1/2a Trial of Stem Cell Treatment for DFU...

CEO Dr. Yona Geffen
attends Bio-Europe Life Science and Innovation Conference in Vienna...

CYTORA presents Phase I/IIa clinical trial diabetic foot ulcer (DFU) efficacy and safety results ...

CYTORA at BioMed
Israel 2025: Harnessing
the unique potential of hOMSC...

CEO Dr. Yona Geffen
presents latest clinical studies at SACHS BEFI Conference...

CYTORA participates
in RESI Boston 2025
Virtual Partnering
Event...

CYTORA presents interim Phase I at International
MSA Congress
Boston 2025...